Chris Drakeley Selected Research

Glucosephosphate Dehydrogenase Deficiency

10/2021	Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
1/2021	G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
8/2018	Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
11/2017	Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda.
1/2017	Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
8/2015	Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test.
8/2014	Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
2/2014	Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
6/2013	Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.
3/2013	Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chris Drakeley Research Topics

Disease

123	Malaria 10/2022 - 03/2003
49	Infections 01/2022 - 01/2012
22	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022 - 07/2002
12	Glucosephosphate Dehydrogenase Deficiency 10/2021 - 05/2009
10	Hemolysis 10/2021 - 05/2010
5	Anemia 10/2021 - 03/2005
4	Fever (Fevers) 11/2021 - 11/2008
4	Parasitemia 01/2021 - 01/2015
3	Vivax Malaria 01/2022 - 01/2017
2	Filarial Elephantiasis (Lymphatic Filariasis) 01/2022 - 05/2013
2	Communicable Diseases (Infectious Diseases) 01/2022 - 12/2019
2	Bites and Stings (Sting) 07/2021 - 10/2019
2	Asymptomatic Infections 01/2020 - 03/2016
2	Body Weight (Weight, Body) 01/2017 - 05/2010
1	Headache (Headaches) 01/2022
1	Cerebral Malaria 10/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020
1	Rabies (Hydrophobia) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Thalassemia 11/2017
1	Hemolytic Anemia 01/2017
1	Trachoma 02/2015
1	Opportunistic Infections (Opportunistic Infection) 01/2015
1	Onchocerciasis 05/2013

Drug/Important Bio-Agent (IBA)

30	Antimalarials (Antimalarial Agents)IBA 03/2022 - 04/2003
29	AntigensIBA 10/2022 - 01/2009
25	AntibodiesIBA 01/2022 - 09/2008
23	Primaquine FDA Link 01/2022 - 05/2010
19	artemisinin (artemisinine)IBA 01/2022 - 09/2006
15	Pharmaceutical PreparationsIBA 01/2022 - 05/2010
12	InsecticidesIBA 07/2021 - 11/2004
11	Immunoglobulin G (IgG)IBA 01/2022 - 01/2012
11	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2021 - 05/2010
11	pyrimethamine drug combination fanasil (Fansidar)FDA Link 03/2021 - 07/2002
11	Proteins (Proteins, Gene)FDA Link 03/2021 - 07/2015
11	VaccinesIBA 01/2020 - 04/2011
10	Merozoite Surface Protein 1 (MSA1)IBA 07/2019 - 05/2009
9	artenimol (dihydroartemisinin)IBA 01/2022 - 03/2015
9	piperaquineIBA 01/2022 - 03/2015
7	EnzymesIBA 01/2020 - 01/2009
6	Indicators and Reagents (Reagents)IBA 03/2020 - 12/2007
5	Ivermectin (Mectizan)FDA Link 01/2022 - 05/2013
5	Hemoglobins (Hemoglobin)IBA 10/2021 - 03/2005
5	Histidine (L-Histidine)FDA Link 03/2021 - 01/2016
5	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2019 - 04/2005
5	ArtesunateIBA 03/2015 - 03/2003
4	Amodiaquine (Camoquin)FDA Link 03/2021 - 07/2002
4	Malaria VaccinesIBA 01/2018 - 01/2012
3	Complement System Proteins (Complement)IBA 02/2022 - 01/2014
3	Biological ProductsIBA 01/2022 - 09/2007
3	glucose-6-phosphate dehydrogenase A-IBA 01/2021 - 05/2010
3	ImmunosorbentsIBA 01/2020 - 01/2009
3	Salivary Proteins and PeptidesIBA 10/2019 - 01/2012
3	Chloroquine (Aralen)FDA LinkGeneric 01/2017 - 04/2003
3	Pyrethrins (Pyrethroids)FDA Link 11/2016 - 09/2007
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 08/2015
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 10/2020 - 01/2018
2	GlobinsIBA 11/2017 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 04/2015
2	Sulfadoxine (Sulformethoxine)FDA Link 01/2009 - 04/2003
2	Pyrimethamine (Daraprim)FDA Link 04/2005 - 04/2003
1	N-methylchlorphentermineIBA 01/2022
1	tafenoquineIBA 01/2022
1	artesunate drug combination pyronaridine tetraphosphateIBA 01/2022
1	18S Ribosomal RNAIBA 01/2021
1	NucleotidesIBA 01/2021
1	Immunoglobulin IsotypesIBA 01/2021
1	BuffersIBA 11/2020
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2019
1	3-O-(methylthiomethyl)apiitol tetraacetateIBA 08/2019
1	ElementsIBA 01/2019
1	Immune Sera (Antisera)IBA 01/2019
1	methyl 1- ribofuranosyl- 1,2,4- triazole- 3- carboxamidateIBA 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	HaptoglobinsIBA 01/2018
1	Sickle HemoglobinIBA 11/2017
1	ORALIT (ORS)IBA 10/2017
1	Blood Group Antigens (Blood Groups)IBA 01/2017
1	(2,3,5,6- tetrafluoro- 4- methoxymethylphenyl)methyl- 2,2- dimethyl- 3- (1- propenyl)cyclopropanecarboxylateIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 12/2016
1	Nucleic AcidsIBA 12/2015
1	Phosphates (Orthophosphate)IBA 08/2015
1	Recombinant ProteinsIBA 07/2015
1	Methylene Blue (Methylthioninium Chloride)FDA Link 03/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2015
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2015
1	Genetic Markers (Genetic Marker)IBA 07/2014
1	1,4-thiomorpholine-3,5-dicarboxylic acidIBA 07/2013
1	Drug CombinationsIBA 08/2011
1	ArtemisininsIBA 05/2010

Therapy/Procedure

16	Mass Drug Administration 02/2022 - 03/2003
15	Therapeutics 01/2022 - 09/2006
5	Aftercare (After-Treatment) 01/2022 - 10/2007
3	Chemoprevention 03/2021 - 01/2018
2	Insecticide-Treated Bednets 01/2020 - 03/2005
1	Treatment Delay 10/2020
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Mosquito Nets 01/2017